Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The mechanism is thought to involve FAK (focal adhesion kinase) and paxillin signaling, but the specific binding target for BPC 157 on a cell surface receptor has not been definitively identified and published as of 2026
BPC-157 & TB500 BLEND 10MG: Key Research Facts BPC-157: Mechanism of Action BPC-157 promotes tissue repair through multiple overlapping pathways
It helps lower blood sugar, delay emptying of the stomach, and regulate appetite
This material is supplied exclusively for controlled laboratory research and analytical reference purposes and is not intended for clinical, therapeutic, consumer, metabolic, or pharmaceutical use
Novo Nordisk files for FDA approval of CagriSema (December 18, 2025)
GLP-1 signaling affects appetite and glucose regulation
